|
MRK's Net Cash Flow Growth by Quarter and Year
Merck And Co Inc 's Net Cash Flow results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
Net Cash Flow Growth Y/Y▼
|
Net Cash Flow Growth Y/Y▼
|
MRK Net Cash Flow (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
IV Quarter |
December |
1,494.00
|
-1,879.00
|
764.00
|
1,967.00
|
III Quarter |
September |
1,526.00
|
1,416.00
|
-3,746.00
|
1,307.00
|
II Quarter |
June |
1,139.00
|
1,619.00
|
3,687.00
|
-1,307.00
|
I Quarter |
March |
447.00
|
-1,142.00
|
-2,474.00
|
0.00
|
FY |
|
4,606.00
|
14.00
|
-1,769.00
|
1,967.00
|
MRK Net Cash Flow fourth quarter 2022 Y/Y Growth Comment |
Merck and Co Inc in the fourth quarter 2022 achieved Net Cash Flow of $ 1,494.00 millions compare to net cash outflow recorded in same quarter a year ago.
Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 64 other companies have achieved higher Net Cash Flow growth. While Merck And Co Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 589 in the fourth quarter 2022.
|
MRK Net Cash Flow ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
IV Quarter |
December |
- |
- |
-61.16 % |
- |
III Quarter |
September |
7.77 % |
- |
- |
- |
II Quarter |
June |
-29.65 % |
-56.09 % |
- |
- |
I Quarter |
March |
- |
- |
- |
- |
FY |
|
32800 % |
- |
- |
- |
MRK Net Cash Flow (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
IV Quarter |
December |
-2.1 % |
- |
- |
50.5 % |
III Quarter |
September |
33.98 % |
-12.54 % |
- |
- |
II Quarter |
June |
154.81 % |
- |
- |
- |
I Quarter |
March |
- |
- |
- |
- |
FY (Year on Year) |
|
32800 % |
- |
- |
- |
Net Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
32800 % |
1274.93 % |
-513.3 % |
(Dec 31 2022) |
|
(Sep. 30, 2007) |
|
Net Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
32800 % |
1274.93 % |
-513.3 % |
(Dec 31 2022) |
|
(Sep. 30, 2007) |
|
Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Merck And Co Inc 's Q/Q Net Cash Flow Growth
Net Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
17008.42 % |
662.15 % |
-100 % |
(Dec. 30, 2005) |
|
|
MRK's IV. Quarter Q/Q Net Cash Flow Comment |
In the IV. Quarter 2022 Merck And Co Inc disclosed fall in Net Cash Flow from the third quarter by -2.1% to $ 1,494.00 millions, from $ 1,526.00 millions declared a quarter before.
Within Major Pharmaceutical Preparations industry 14 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is 402. |
|
|
Net Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
17008.42 % |
662.15 % |
-100 % |
(Dec. 30, 2005) |
|
|
MRK's IV. Quarter Q/Q Net Cash Flow Comment |
In the IV. Quarter 2022 Merck And Co Inc realized fall in Net Cash Flow from the third quarter by -2.1% to $ 1,494.00 millions, from $ 1,526.00 millions achived in the previous quarter.
Within Major Pharmaceutical Preparations industry 14 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is 402. |
|
Merck And Co Inc 's 12 Months Net Cash Flow Growth Year on Year
Net Cash Flow TTM Growth |
12 Months Ending (Sep 30 2022) |
12 Months Ending (Jun 30 2022) |
12 Months Ending (Mar 31 2022) |
12 Months Ending (Dec 31 2021) |
12 Months Ending (Sep 30 2021) |
Cumulative Net Cash Flow 12 Months Ending |
$ 1,233.00 |
$ 1,123.00 |
$ 1,603.00 |
$ 14.00 |
$ 2,657.00 |
Y / Y Net Cash Flow Growth (TTM) |
-53.59 % |
- |
- |
- |
- |
Year on Year Net Cash Flow Growth Overall
Ranking |
# |
# |
# |
# |
# |
Seqeuential Net Cash Flow Change (TTM) |
9.8 % |
-29.94 % |
11350 % |
-99.47 % |
- |
Seq. Net Cash Flow Growth (TTM) Overall
Ranking |
# 634 |
# 0 |
# 0 |
# 0 |
# 0 |
Cumulative Net Cash Flow growth
Comment |
Merck And Co Inc showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in Jun 30 2022. If the fiscal year would end in Sep 30 2022, Merck And Co Inc 's annual Net Cash Flow drop would be -53.59% year on year to $1,233 millions.
Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to , from total ranking in previous quarter at 1273. |
Net Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
32800 % |
1274.93 % |
-513.3 % |
|
|
|
|
|
Net Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
32800 % |
1120.82 % |
-513.3 % |
(Dec 31 2022) |
|
|
Net Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 65 |
Sector |
# 122 |
S&P 500 |
# 634 |
|
Cumulative Net Cash Flow growth
Comment |
Merck And Co Inc showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in Jun 30 2022. If the fiscal year would end in Sep 30 2022, Merck And Co Inc 's annual Net Cash Flow drop would be -53.59% year on year to $1,233 millions.
Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to , from total ranking in previous quarter at 1273. |
Net Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
32800 % |
1274.93 % |
-513.3 % |
|
|
|
Net Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
32800 % |
1120.82 % |
-513.3 % |
(Dec 31 2022) |
|
|
Net Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 65 |
Sector |
# 122 |
S&P 500 |
# 634 |
|